EDMONTON, AB. – July 19th, 2017 – The provincial/territorial Premiers met today at the Council of the Federation in Edmonton, Alberta. Health was on the agenda. Patient groups, patients, caregivers and their supporters were in Edmonton to follow the outcome of the meeting. They wanted to ensure that the decisions made enhanced access to necessary life-saving, life-extending and significant quality of life-enhancing treatments to Canadians
Month: July 2017
Cotellic (Cobimetinib) in Québec
COBIMETINIB: in association with vemurafenib, for first-line or second-line treatment following a failure with cytotoxic chemotherapy or with immunotherapy targeting the PD-1 or the CTLA-4, of an unresectable or metastatic melanoma with a BRAF V600 mutation, in persons whose ECOG performance status is 0 or 1. The initial authorization is for a maximum duration of four months. Upon subsequent requests, the physician must provide evidence
Premiers Council of the Federation Meetings Signal Positive Direction in Health but the Devil is in the Details
EDMONTON, AB. – July 18th, 2017 – The provincial/ territorial Premiers are meeting today and tomorrow at the Council of the Federation meeting in Edmonton, Alberta. Patient groups, patients, caregivers and their supporters in Edmonton to follow the outcomes of the meeting. They are calling on the attendees to ensure that the decisions they make will not limit access to necessary life-saving, life-extending and significant
Watch our webinar titled “Learn about the Canadian Association of Provincial Cancer Agencies (CAPCA) from its Executive Director, Heather Logan”
CAPCA wants to make sure that patients have access to innovative and effective cancer treatments, and Heather Logan, ED of CAPCA, explains how CAPCA is going to do this and answer your questions about the process. This webinar introduces you to CAPCA and its mandate and to the new pan-Canadian Cancer Drug Funding Sustainability Initiative (DFSI). The goal of DFSI is to ensure that patients